These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2474928)

  • 1. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].
    Stiehl A; Raedsch R
    Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].
    Raedsch R; Stiehl A
    Klin Wochenschr; 1989 Feb; 67(4):265-8. PubMed ID: 2648062
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM; Rybicki LA; Lashner BA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G; Endele R; Senn M; Stiehl A
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.
    Stiehl A; Walker S; Stiehl L; Rudolph G; Hofmann WJ; Theilmann L
    J Hepatol; 1994 Jan; 20(1):57-64. PubMed ID: 8201224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of asymptomatic primary sclerosing cholangitis treated by ursodeoxycholic acid].
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N; Mitake M; Nakazawa S; Okuyama S
    Nihon Naika Gakkai Zasshi; 1989 Jan; 78(1):89-90. PubMed ID: 2732582
    [No Abstract]   [Full Text] [Related]  

  • 8. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N
    Gastroenterology; 1990 Aug; 99(2):533-5. PubMed ID: 2365199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
    Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
    Leuschner U; Fischer H; Hübner K
    Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis. Ursodeoxycholic acid is without clinical effect].
    Eisenburg J
    Fortschr Med; 1997 Jun; 115(18):7-8. PubMed ID: 9324488
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Stiehl A
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case.
    Fujita Y; Sugaya T; Inui A; Yoshihara S
    Tohoku J Exp Med; 2021 Feb; 253(2):109-112. PubMed ID: 33551380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Silveira MG; Lindor KD
    J Hepatol; 2008 May; 48(5):692-4. PubMed ID: 18336948
    [No Abstract]   [Full Text] [Related]  

  • 16. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe backache in clinically inactive ulcerative colitis].
    Coenen C; Wegener M; Wedmann B
    Fortschr Med; 1993 Oct; 111(30):476-8. PubMed ID: 7903077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?
    Chapman RW
    Hepatology; 2009 Sep; 50(3):671-3. PubMed ID: 19714717
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
    Charatcharoenwitthaya P; Lindor KD
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis.
    Noda H; Chiba F; Toyama N; Konishi F
    J Hepatobiliary Pancreat Surg; 2009; 16(1):83-5. PubMed ID: 19096754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.